JP2020533301A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533301A5
JP2020533301A5 JP2020513648A JP2020513648A JP2020533301A5 JP 2020533301 A5 JP2020533301 A5 JP 2020533301A5 JP 2020513648 A JP2020513648 A JP 2020513648A JP 2020513648 A JP2020513648 A JP 2020513648A JP 2020533301 A5 JP2020533301 A5 JP 2020533301A5
Authority
JP
Japan
Prior art keywords
variant polypeptide
composition
mutated
composition according
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020513648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533301A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/049648 external-priority patent/WO2019051015A1/en
Publication of JP2020533301A publication Critical patent/JP2020533301A/ja
Publication of JP2020533301A5 publication Critical patent/JP2020533301A5/ja
Priority to JP2023133442A priority Critical patent/JP2023157959A/ja
Pending legal-status Critical Current

Links

JP2020513648A 2017-09-06 2018-09-06 インターロイキン−１８バリアントとその利用法 Pending JP2020533301A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023133442A JP2023157959A (ja) 2017-09-06 2023-08-18 インターロイキン－１８バリアントとその利用法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762554605P 2017-09-06 2017-09-06
US62/554,605 2017-09-06
US201862652279P 2018-04-03 2018-04-03
US62/652,279 2018-04-03
PCT/US2018/049648 WO2019051015A1 (en) 2017-09-06 2018-09-06 VARIANTS OF INTERLEUKIN-18 AND METHODS OF USE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023133442A Division JP2023157959A (ja) 2017-09-06 2023-08-18 インターロイキン－１８バリアントとその利用法

Publications (2)

Publication Number Publication Date
JP2020533301A JP2020533301A (ja) 2020-11-19
JP2020533301A5 true JP2020533301A5 (OSRAM) 2021-10-14

Family

ID=65517760

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020513648A Pending JP2020533301A (ja) 2017-09-06 2018-09-06 インターロイキン−１８バリアントとその利用法
JP2023133442A Pending JP2023157959A (ja) 2017-09-06 2023-08-18 インターロイキン－１８バリアントとその利用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023133442A Pending JP2023157959A (ja) 2017-09-06 2023-08-18 インターロイキン－１８バリアントとその利用法

Country Status (13)

Country Link
US (6) US20190070262A1 (OSRAM)
EP (1) EP3678681A4 (OSRAM)
JP (2) JP2020533301A (OSRAM)
KR (1) KR20200066623A (OSRAM)
CN (1) CN111315395A (OSRAM)
AU (2) AU2018330444B2 (OSRAM)
BR (1) BR112020004389A2 (OSRAM)
CA (1) CA3080492A1 (OSRAM)
IL (2) IL272635B2 (OSRAM)
MX (1) MX2020002542A (OSRAM)
SG (1) SG11202001384TA (OSRAM)
WO (1) WO2019051015A1 (OSRAM)
ZA (1) ZA202307212B (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12029778B2 (en) 2019-05-13 2024-07-09 Yale University Interleukin-18 mimics and methods of use
WO2021231447A1 (en) * 2020-05-12 2021-11-18 Regeneron Pharmaceuticals, Inc. Novel il10 agonists and methods of use thereof
JP2023538422A (ja) * 2020-08-19 2023-09-07 ブライト ピーク セラピューティクス エージー 修飾ｉｌ－１８ポリペプチドおよびその使用
MX2023005068A (es) * 2020-11-02 2023-07-14 Simcha Il 18 Inc Variantes de interleucina-18 y métodos de uso.
US20240150421A1 (en) 2021-02-10 2024-05-09 Nagasaki University Novel human interleukin-18 variant and use thereof
WO2023010021A1 (en) 2021-07-27 2023-02-02 Xencor, Inc. Il-18-fc fusion proteins
JP2023024168A (ja) 2021-08-06 2023-02-16 国立大学法人 長崎大学 がんの治療剤
CA3237618A1 (en) 2021-12-15 2023-06-22 Genentech, Inc. Stabilized il-18 polypeptides and uses thereof
WO2023118497A1 (en) * 2021-12-22 2023-06-29 Pieris Pharmaceuticals Gmbh Novel il-18 variants
EP4482856A1 (en) 2022-02-23 2025-01-01 Bright Peak Therapeutics AG Activatable il-18 polypeptides
CN119053347A (zh) 2022-02-23 2024-11-29 明峰治疗股份公司 免疫抗原特异性il-18免疫细胞因子及其用途
US20230357342A1 (en) * 2022-02-23 2023-11-09 Bright Peak Therapeutics Ag Modified il-18 polypeptides
US20250297018A1 (en) 2022-03-15 2025-09-25 Compugen Ltd. Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancer
EP4519678A1 (en) * 2022-05-05 2025-03-12 Hospital Espanol Auxilio Mutuo de Puerto Rico, Inc. Methods for treating bladder cancer
AU2023320522A1 (en) * 2022-08-05 2025-01-23 Fuse Biotherapeutics Inc. Il-18 fusion proteins and methods of producing il-18
WO2024044780A1 (en) * 2022-08-26 2024-02-29 Sutro Biopharma, Inc. Interleukin-18 variants and uses thereof
WO2024051728A1 (en) * 2022-09-06 2024-03-14 I-Mab Biopharma Co., Ltd. Il-18 variant polypeptides
WO2024086852A1 (en) * 2022-10-21 2024-04-25 Diagonal Therapeutics Inc. Heteromeric agonistic antibodies to il-18 receptor
US20240166705A1 (en) * 2022-11-07 2024-05-23 Xencor, Inc. Il18-fc fusion proteins
JP2025538787A (ja) 2022-12-07 2025-11-28 広州威溶特医薬科技有限公司 抗腫瘍薬の調製におけるｄｒ－１８と腫瘍溶解性ワクシニアウイルスの使用
KR20250133728A (ko) 2023-01-06 2025-09-08 라센 테라퓨틱스, 인코포레이티드 항-il-18bp 항체
EP4646270A2 (en) * 2023-01-06 2025-11-12 Alector LLC Anti-il18 binding protein antibodies and methods of use thereof
TW202430560A (zh) * 2023-01-06 2024-08-01 美商拉森醫療公司 抗ｉｌ－１８ｂｐ抗體
AU2024211503A1 (en) * 2023-01-24 2025-07-31 Msd International Business Gmbh Methods and compositions for combination therapy
WO2024251983A1 (en) * 2023-06-09 2024-12-12 Merck Patent Gmbh Il-18 mimetics
TW202515608A (zh) 2023-06-26 2025-04-16 以色列商坎布根有限公司 Ｉｌ—１８ｂｐ拮抗抗體及其於癌症治療之單一療法及組合療法的用途
WO2025015103A1 (en) * 2023-07-10 2025-01-16 The Children's Hospital Of Philadelphia Methods for modulating activity of il-18 for treatment of cd4+ t cell mediated autoimmunity and immunopathology
US20250186597A1 (en) 2023-08-23 2025-06-12 Bright Peak Therapeutics Ag Targeted immune activation with il-18 immunocytokines
WO2025041097A1 (en) 2023-08-23 2025-02-27 Bright Peak Therapeutics Ag Il-18 polypeptides fused to immune cell antigen specific binding polypeptides and uses thereof
US20250197467A1 (en) 2023-08-23 2025-06-19 Bright Peak Therapeutics Ag Activatable il-18 immunocytokines and uses thereof
WO2025068413A1 (en) 2023-09-28 2025-04-03 Prokarium Limited Interleukin 18 variants
WO2025085447A1 (en) 2023-10-17 2025-04-24 Xencor, Inc. Pd-1 targeted il18-fc fusion proteins
CN120093897A (zh) * 2023-12-04 2025-06-06 广州威溶特医药科技有限公司 Dr-18和单纯疱疹病毒在制备抗肿瘤药物中的应用
CN120189493A (zh) 2023-12-22 2025-06-24 广州威溶特医药科技有限公司 Dr-18和m1病毒在制备抗肿瘤药物中的应用
US12134635B1 (en) 2023-12-29 2024-11-05 Sonnet BioTherapeutics, Inc. Interleukin 18 (IL-18) variants and fusion proteins comprising same
WO2025151273A1 (en) * 2024-01-08 2025-07-17 Adimab, Llc Il-18 polypeptides and uses thereof
WO2025242835A1 (en) 2024-05-22 2025-11-27 Ose Immunotherapeutics Molecules comprising masking linkers and uses thereof for the treatment of cancer
WO2025251226A1 (en) 2024-06-05 2025-12-11 Nuwacell Biotechnologies Co., Ltd. Use of interleukin-21 and interleukin-15 for enhancing serial killing of natural killer cell for cell therapy against target cell

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595756A (en) 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US6479258B1 (en) 1995-12-07 2002-11-12 Diversa Corporation Non-stochastic generation of genetic vaccines
US6713279B1 (en) 1995-12-07 2004-03-30 Diversa Corporation Non-stochastic generation of genetic vaccines and enzymes
EP0816499A3 (en) * 1996-06-27 1999-10-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Genomic DNA encoding a polypeptide capable of inducing the production of interferon-gamma
US6790442B1 (en) 1996-06-27 2004-09-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Genomic DNA encoding a polypeptide capable of inducing the production of interferon-γ
JP4024366B2 (ja) 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
JP3955352B2 (ja) * 1997-02-25 2007-08-08 株式会社林原生物化学研究所 破骨細胞形成阻害剤
TWI227136B (en) * 1998-05-21 2005-02-01 Smithkline Beecham Corp Novel pharmaceutical composition for the prevention and/or treatment of cancer
JP2001266941A (ja) 2000-03-17 2001-09-28 Sony Corp ゲル電解質電池の製造方法
AU2001275166B2 (en) * 2000-06-02 2005-07-28 Smithkline Beecham Corporation Methods of treating viral diseases with il-18 and il-18 combinations
PT1292697E (pt) 2000-06-15 2009-10-28 Smithkline Beecham Corp Método para a preparação de um polipéptido il-18 fisiologicamente activo
US6818444B2 (en) 2000-08-04 2004-11-16 Heska Corporation Canine and feline proteins, nucleic acid molecules and uses thereof
EA005769B1 (ru) 2001-03-08 2005-06-30 Арес Трейдинг С.А. Мутанты интерлейкина-18, их продуцирование и применение
JP2004532033A (ja) 2001-05-04 2004-10-21 コーネル リサーチ ファンデイション インコーポレイテッド 発現し難いタンパク質用の迅速に開裂可能なｓｕｍｏ融合タンパク質発現系
WO2003031569A2 (en) 2001-10-10 2003-04-17 Centocor, Inc. Nucleic acid vaccines using tumor antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acid
US20040023336A1 (en) 2001-10-26 2004-02-05 Heavner George A. Mut-IL-18 or Mut-IL-18R proteins, antibodies, compositions, methods and uses
US6800479B2 (en) 2001-12-11 2004-10-05 Samyang Genex Corporation Recombinant adenoviruses expressing interleukin-18 protein and gene therapy using them
CA2472477C (en) 2002-01-07 2012-03-20 Lifesensors, Inc. Methods and compositions for protein expression and purification
US7220576B2 (en) 2002-01-07 2007-05-22 Lifesensors, Inc. Methods and compositions for protein expression and purification
US7253260B2 (en) 2002-04-17 2007-08-07 Smithkline Beecham Corporation Human IL-18 crystal structure
WO2004002519A1 (en) * 2002-06-27 2004-01-08 Smithkline Beecham Corporation Methods of treating or preventing ibd with il-18
AU2003299919B2 (en) * 2002-10-08 2009-08-06 Ares Trading S.A. The use of cytokine able to bind IL-18BP and of inhibiting the activity of a second cytokine
EP1613274B1 (en) 2003-04-15 2010-03-03 GlaxoSmithKline LLC Human il-18 substitution mutants and their conjugates
PT1622939E (pt) * 2003-05-13 2012-03-28 Merck Serono Sa Variantes ativas da proteína de ligação à il-18 e suas utilizações médicas
EP1654379A4 (en) 2003-06-26 2007-01-17 Lifesensors Inc METHOD AND COMPOSITIONS FOR IMPROVED PROTEIN EXPRESSION AND CLEANING
CA2678736A1 (en) * 2003-07-21 2005-02-17 Transgene S.A. Novel multifunctional il-2 - il-18 fusion proteins
DE602004031341D1 (de) 2003-07-21 2011-03-24 Transgene Sa Multifunktionelle cytokine
WO2005075648A1 (en) * 2004-01-28 2005-08-18 Gifu University Interleukin-18 mutant proteins
EP2161032B1 (en) 2004-08-20 2011-09-28 GlaxoSmithKline LLC Healing of wounds by administering human IL-18
US8119369B2 (en) 2004-12-30 2012-02-21 Lifesensors, Inc. Human SUMO-3 for enhancing protein expression
EP2059253A4 (en) 2006-09-14 2011-09-14 Univ Pennsylvania MODULATION OF T LYMPHOCYTES REGULATORS BY HUMAN IL-18
AU2007342011A1 (en) 2006-12-29 2008-07-10 Lifesensors, Inc. Methods and compositions for enhanced protein expression and purification
WO2009062102A2 (en) 2007-11-07 2009-05-14 Genentech, Inc. Compositions and methods for treatment of microbial disorders
US20110001891A1 (en) 2008-02-27 2011-01-06 Sharp Kabushiki Kaisha Illuminating device, display device, and television receiver
TW200951219A (en) 2008-05-06 2009-12-16 Academia Sinica An improved SUMO fusion protein system for effective production of native proteins
CN101993495B (zh) 2009-08-12 2013-07-24 上海近岸科技有限公司 一种蛋白质混合物及其制备方法
US9316417B2 (en) 2012-06-29 2016-04-19 Sunpower Corporation Framing system for mounting solar collecting devices
BR112015002091A2 (pt) 2012-08-02 2017-12-12 Hoffmann La Roche método para a produção de um polipeptídeo, polipeptídeo, uso de um polipeptídeo e composição
JOP20200308A1 (ar) * 2012-09-07 2017-06-16 Novartis Ag جزيئات إرتباط il-18
WO2015054386A1 (en) 2013-10-08 2015-04-16 Georgia State University Research Foundation, Inc Compositions including il-18 and il-22 and their use in anti-viral therapies
KR102511343B1 (ko) 2015-03-05 2023-03-17 에이비2 바이오 에스에이 염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ) 및 항체
CN108064176A (zh) 2015-04-22 2018-05-22 库瑞瓦格股份公司 用于治疗肿瘤疾病的含有rna的组合物
WO2017102010A1 (en) * 2015-12-17 2017-06-22 Biontech Rna Pharmaceuticals Gmbh Novel cytokine fusion proteins
JP7220458B2 (ja) 2016-02-05 2023-02-10 ワシントン・ユニバーシティ 標的サイトカインデリバリーのための組成物および方法
JP7082604B2 (ja) 2016-03-21 2022-06-08 マレンゴ・セラピューティクス，インコーポレーテッド 多重特異性および多機能性分子ならびにその使用
ITUA20161992A1 (it) 2016-03-24 2017-09-24 Plico Biotech Inc Sumo e suoi utilizzi
AU2017305524B2 (en) 2016-08-04 2024-09-26 Memorial Sloan-Kettering Cancer Center Compositions and methods for immunotherapy
US11566063B2 (en) 2016-09-30 2023-01-31 Baylor College Of Medicine Antibody based gene therapy with tissue-directed expression
TWI591177B (zh) 2016-10-27 2017-07-11 中化合成生技股份有限公司 一種胰高血糖素胜肽－２（ｇｌｐ－２）類似物的製備方法
JP7191030B2 (ja) 2017-03-06 2022-12-16 アルター・バイオサイエンス・コーポレーション Ｉｌ－１２及びｉｌ－１８へのｉｌ－１５系融合
CA3068841A1 (en) 2017-07-03 2019-01-10 Torque Therapeutics, Inc. Fusion molecules targeting immune regulatory cells and uses thereof
EP3788150A4 (en) 2018-05-04 2022-01-26 Sigma-Aldrich Co. LLC PRODUCTION OF RECOMBINANT PROTEINS WITH REDUCED LEVELS OF HOST CELL PROTEINS
CN113365663B (zh) 2018-08-30 2025-11-21 免疫生物公司 单链嵌合多肽和其用途
KR20250160211A (ko) 2018-08-30 2025-11-11 이뮤니티바이오, 인크. 다중-사슬 키메라 폴리펩타이드 및 이의 용도
JP7474769B2 (ja) 2018-08-30 2024-04-25 エイチシーダブリュー バイオロジックス インコーポレイテッド 一本鎖および多鎖キメラポリペプチドならびにその使用方法
CA3125556A1 (en) 2019-01-04 2020-07-09 Repertoire Immune Medicines, Inc. Methods of producing high diversity peptide libraries and promoting protein folding
EP3969035A4 (en) 2019-05-14 2023-06-21 Werewolf Therapeutics, Inc. SEPARATION UNITS AND METHODS AND THEIR USE
WO2020243371A1 (en) 2019-05-28 2020-12-03 Massachusetts Institute Of Technology Methods and compositions for modulating immune responses
WO2020243729A1 (en) 2019-05-31 2020-12-03 Children's National Medical Center Cytokine cocktails for selective expansion of t cell subsets
JP2022545643A (ja) 2019-08-13 2022-10-28 キングス・カレッジ・ロンドン Ｉｌ－１スーパーファミリーのサイトカインの空間時間的に制限された活性が武装化された免疫応答性細胞
EP4041406A4 (en) 2019-10-09 2023-10-18 Dana-Farber Cancer Institute, Inc. COMPOSITIONS AND METHODS FOR TREATING CYTOTOXIC TUMORS RESISTANT TO T CELLS
EP4196149A1 (en) 2020-08-14 2023-06-21 Kite Pharma, Inc. Improving immune cell function
JP2023538422A (ja) 2020-08-19 2023-09-07 ブライト ピーク セラピューティクス エージー 修飾ｉｌ－１８ポリペプチドおよびその使用
MX2023005068A (es) 2020-11-02 2023-07-14 Simcha Il 18 Inc Variantes de interleucina-18 y métodos de uso.
KR20240007179A (ko) 2021-04-30 2024-01-16 셀렉티스 에스.에이. 고형 종양 암 면역 요법을 위한 새로운 항-muc1 car 및 유전자 편집된 면역세포
US20250281638A1 (en) 2021-06-10 2025-09-11 Chimera Bioengineering, Inc. Compositions and Methods for Activating Natural Killer Cells

Similar Documents

Publication Publication Date Title
JP2020533301A5 (OSRAM)
JP7744479B2 (ja) 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体
JP7223822B2 (ja) 抗ヒトパピローマウイルス１６ ｅ６ ｔ細胞受容体
US12312391B2 (en) Anti-mutated KRAS T cell receptors
Klein et al. Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
Hahn et al. The future of immune checkpoint cancer therapy after PD-1 and CTLA-4
GB2617483A (en) Interleukin-18 variants and methods of use
CN113784976B (zh) 用于鉴定抗原特异性t细胞的组合物和方法
JP2020508691A (ja) Ｉｌ−１２及びｉｌ−１８へのｉｌ−１５系融合
JPWO2022094473A5 (OSRAM)
JPWO2020113164A5 (OSRAM)
WO2020152161A1 (en) Specific t cell receptors against epitopes of mutant myd88l265p protein for adoptive t cell therapy
CN116322715A (zh) 经改造t细胞受体和使用方法
AU2020373899A1 (en) Drug for treating cancer, combination drug, drug composition, immune responsive cell, nucleic acid delivery vehicle, and product
US20250302953A1 (en) Methods of treating patients exhibiting a prior failed therapy with hypoimmunogenic cells
Patterson et al. Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen
CN111601817A (zh) 分泌il-33的免疫应答细胞及其用途
CN114980907A (zh) 增强细胞癌症治疗的t细胞死亡相关基因8(tdag8)调节
EP4157863A2 (en) Engineered immune cells, compositions and methods thereof
US20240424098A1 (en) Modified immune cells and methods of use thereof
RU2020112538A (ru) Варианты интерлейкина-18 и способы их применения
TWI905347B (zh) 用於調變ｃａｒ－ｔ活性之方法與組成物
CN120758457A (zh) 改造的免疫细胞、靶向Mettl13基因的gRNA和应用
JPWO2019145453A5 (OSRAM)
CN120380014A (zh) 靶向vcy抗原的肽和经改造t细胞受体及使用方法